Frontlight ResearchEarly access
Trial site
Splosna Bolnisnica Murska Sobota
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Heart failure2 trials
- Alzheimer disease1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- AbbVie1 trial
- Abivax1 trial
- Abivax S.A.1 trial
- Boehringer Ingelheim1 trial
- Otsuka Pharmaceutical Development & Commercialization Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026